SlideShare a Scribd company logo
Dr. Anshulekha Patel
Moderator- Dr. (Prof) P.K.Satpathy
Guide-Dr. (Prof) Raghumani Mohanty
GENETIC ORIGINS OF HUMAN
CANCER- RECENT ADVANCES
INTRODUCTION
 1916 : Tyzzer first use the term ‘somatic mutation’
to designate events occuring in cancer
progression.
 1954 : Armitage and Doll proposed multi-stage
theory of carcinogenesis
 1971 : Knudson proposed two-hit model of
retinoblastoma
 1990: Fearson and Vogelstein analysed
colorectal tumour progression and provided
support for multistep cancer progression model.
ARMITAGE DOLL MODEL
KNUDSON’S TWO HIT
HYPOTHESIS
THE MULTISTEP CANCER
PROGRESSION MODEL
 Tumors progressively accumulate carcinogenic
mutations or other genetic changes.
 The alterations involve tumour suppressor genes
and oncogenes and occur in a stepwise fashion.
 Multistep cancer progression model emphasises
on the order in which the genetic changes
occur.
 It provides the basis for initiation, growth ,
progression and metastatic spread of cancer.
COLORECTAL
TUMORIGENESIS
THE MULTISTEP CANCER
PROGRESSION MODEL
 Colorectal cancer
 Pancreatic cancer
 Breast cancer
 During progressive clonal evolution, selectively
advantageous ‘driver’ lesions lead to acquisition
of the phenotypic ‘hallmarks of cancer’.
HALLMARKS OF CANCER
THE MULTISTEP CANCER
PROGRESSION MODEL
 An initial mutation that confers a selective
advantage is acquired by a cell and leads to
clonal expansion of these cells.
 The first cell is probably a stem cell.
 A further mutation occurs which is again selected
to clonally expand replacing the other cells in the
population- this is called selective sweep.
SEQUENTIAL MODEL OF CANCER
PROGRESSION
Subsequent mutations in the key driver genes to cells
within the clone trigger subsequent clonal expansions,
and each clone takes over the entire neoplasm (A
SWEEP TO FIXATION)
THE MULTISTEP CANCER
PROGRESSION MODEL
 The accural of driver mutations in this stepwise
fashion underpins the progression to an invasive
or metastatic phenotype.
 In the colon, genetic model involves sequential
mutations in the APC, KRAS and TP53 genes.
 In Barrrett’s oesophagus, early mutation of p16 is
followed by later inactivation of TP53.
BARRETT’S OESOPHAGUS
BARRETT’S OESOPHAGUS
 The pattern of mutation and clonal expansion as
proposed by Maley et al.
 An initial founder mutation, usually LOH of p16,
provides a cell with a selective advantage and so
it sweeps across the entire Barrett's oesophagus
segment to fixation. Subsequent mutations and
selective sweeps, typically a second hit at the p16
locus or a mutation or LOH of p53 cause later
selective sweeps, sometimes also to fixation. The
linear accumulation of mutations eventually
produces a cancerous clone.
COLORECTAL
TUMORIGENESIS
COLORECTAL
TUMORIGENESIS
COLORECTAL
TUMORIGENESIS
COLORECTAL
TUMORIGENESIS
COLORECTAL
TUMORIGENESIS
 Based on assumption that all somatic mutations
occurred clonally in an adenoma- present in all its
cells, but beginning with the cell of origin or stem
cell.
 The mutations accumulate within the adenoma by
wave of selective sweeps, which go to fixation
throughout the adenoma.
 So, it follows that adenomas should be ‘
genetically homogenous benign lesion(s)’.
PROBLEMS WITH THE
CLASSICAL MULTISTEP
CANCER PROGRESSION
MODEL
PROBLEMS WITH THE CLASSICAL
MULTISTEP CANCER PROGRESSION
MODEL
 It suggests there has to be an order in which
mutations occur.
 Clinically this is appealing –might be amenable to
therapeutic attack and milestones of prognosis
 Eg in the progression of Barrett’s oesophagus,
p16 deletion is followed by loss of TP53. So,
TP53 lesion is closer to becoming
cancerous…….?? Such deterministic
progression with a fixed order of selection is
UNLIKELY
PROBLEMS WITH THE CLASSICAL
MULTISTEP CANCER PROGRESSION
MODEL
 Tumours develop through variable pathways, and
that the order of mutation/ selection is mainly
stochastic.
 Microenvironment plays an important role in the
selection for mutant genes.
 Driver mutations are detected in normal tissue.
Eg p53 and oncogene mutations in both skin and
nondysplastic colon epithelium in inflammatory
bowel disease.
PROBLEMS WITH THE CLASSICAL
MULTISTEP CANCER PROGRESSION
MODEL
 Selective sweeps are rare in human tumours.
 Studies on Barrett’s oesophagus supported
concept of small, localised clonal expansions.
INTRATUMOUR
HETEROGENEITY
PROBLEMS WITH THE CLASSICAL
MULTISTEP CANCER PROGRESSION
MODEL
•Multiple clones exist throughout the follow-up period.
•In only one case, a clone grew to dominate the Barrett’s
segment without real evidence that the clone swept to
fixation.
PROBLEMS WITH THE CLASSICAL
MULTISTEP CANCER PROGRESSION
MODEL
 In colorectal adenomas progressing to
carcinomas, there are no selective sweeps.
 Adenomas are not genetically homogenous but
they show a complex regional genetic structure,
with segregated clones that correlate with the
histological appearances.
PROBLEMS WITH THE CLASSICAL
MULTISTEP CANCER PROGRESSION
MODEL
 Genetic mosaicism is a feature of most, if not all,
cancers.
 Kidney cancer
 Lung cancer
 Breast
 Glioma
 Leukemia
 Ovary
 Genetic differences are observed between
primary tumour and associated metastases.
Assumption made in the classical multistep
cancer progression model- that mutations
sequentially spread throughout the tumour,
creating a genetically homogenous lesion in
which all cells share the same mutations- are
inconsistent with currently available data.
A BIG BANG
 A new proposed model of colorectal cancer
growth.
A BIG BANG
 Colorectal cancers grow as a single(clonal) expansion
rather than evolving sequentially via multiple selective
sweeps.
 Composition of subclones that naturally arise within
the single expansion do not experience stringent(
differential) selection. That means tumour are
heterogenous. Acquiring a new driver mutation
doesnot trigger a selective sweep.
 Because of lack of selection, the timing of mutation,
rather than selection, is main determinant of clone
size within the tumour. Mutations arising early will
tend to have large subclones and those arising late
will form clones of restricted size.
A BIG BANG
 The Big Bang model was postulated to explain
the results of a detailed genetic analysis of
intratumour diversity in colorectal cancers and
adenoma.
 The spatial distribution of point mutations and
copy number alterations across different regions
of these tumours was recorded and
computational modelling approach was used to
determine the most likely way in which tumour
would progress.
A BIG BANG
 The computational analysis revealed that sequential
model was extremely unlikely to explain the
obsereved spatial distribution of subclones.
 It predicted that all the sizeable subclones arose early
during the cancer expansion, and their size was not
determined by their fitness.
 But it is based on the fact that a tumour consists of an
almost innumerable population of cells. 1 cm3 tumour
is lower size limit of clinical detection but already
contains one billion cells.
A BIG BANG
After initiation, a tumor grows predominantly as a single expansion
numerous heterogeneous subclones.
ITH results from private alterations (colored arrowheads) that contin
accumulate owing to replication errors.
ABSTRACT OF BIG BANG
ARTICLE
 What happens in early, still undetectable human
malignancies is unknown because direct observations are
impractical. Here we present and validate a 'Big Bang'
model, whereby tumors grow predominantly as a single
expansion producing numerous intermixed subclones that
are not subject to stringent selection and where both public
(clonal) and most detectable private (subclonal) alterations
arise early during growth. Genomic profiling of 349
individual glands from 15 colorectal tumors showed an
absence of selective sweeps, uniformly high intratumoral
heterogeneity (ITH) and subclone mixing in distant regions,
as postulated by our model. We also verified the prediction
that most detectable ITH originates from early private
alterations and not from later clonal expansions, thus
exposing the profile of the primordial tumor. Moreover,
some tumors appear 'born to be bad', with subclone
mixing indicative of early malignant potential. This new
model provides a quantitative framework to interpret tumor
growth dynamics and the origins of ITH, with important
clinical implications.
AVENUE FOR FUTURE
RESEARCH
 Clinically, the Big Bang model raises the question
of whether cancers are ‘ born to be bad.’
 If the clonal composition of the tumour is
essentially fixed from the outset of tumour growth,
then the early events will determine the prognosis
of tumour and its sensitivity to treatment.
 In Authors’ opinion Big Bang dynamics could
apply equally well in other tumour types but is still
undetermined.
PUNCTUATED EQUILIBRIA AND
HOPEFUL MONSTERS
Sequential model
assumes that the driver
mutations accrue
sequentially (phyletic
gradualism)
Big bang model is an
example of punctuated
equilibrium. Large
phenotypic leaps occur
suddenly in a static
population
PUNCTUATED EQUILIBRIA AND
HOPEFUL MONSTERS
 Punctuated equilibria evolutionary model is a
model purely of the pattern of phenotypic change
in a population.
 It makes no comment on pattern of genotypic
change.
 Genotypic phenotype relationship is complex.
1. Small genotype changes can have large
phenotypic consequences.(eg. single base pair
change in APC cause Hereditary polyosis
syndrome)
2. Cell’s phenotype is defined in conjunction with
PUNCTUATED EQUILIBRIA AND
HOPEFUL MONSTERS
 Individuals with grossly altered genomes are
referred to as ‘hopeful monsters’.
 ‘Hopefulness’ derives from the chance that the
alterations will provide significant increase in
fitness to the mutated individual.
 Question arises: Is the development of a hopeful
monster a plausible cause of Big Bang????
GENETIC INSTABILITY,
CHROMOSOMAL CATASTROPHES AND
CONSPIRING CLONES
 85% of colon cancers show chromosomal
instability (CIN) in the form of loss and gain of
whole chromosome arms.
 15% show increased point mutations that lead to
defect in mismatch repair (MMR) or defect in
other DNA replication and repair enzymes.
 Both causes elevated rates of ongoing genetic
change, and increase the rate at which driver
mutations accrue.
MICROSATELLITE INSTABILITY
(MSI)
 MSI is a result of defects in the mismatch repair
proteins (genes) hMSH2,
hMLH1,hPMS1,hPMS2,and hMSH6.
 MSI-H cancers tend to be diploid and have wild
type p53 compared with MSS cancers.
 MSI-H present at a lower stage and have better
survival.
INSTABILITY IN TUMOUR
CELLS
NIH classification
30% (≥ 2 of 5 microsatellites) MSI-H
10-30% MSI-L
<10% MSS
GENETIC INSTABILITY,
CHROMOSOMAL CATASTROPHES AND
CONSPIRING CLONES
 A steady accural of mutations could underpin
punctuated evolution if certain conditions are met
1. Driver mutation must be rare enough that
periods of time sufficient for a selective sweep
elapse between each sequential driver
mutation.
2. The accrual of a single new driver mutation
must cause a significant change in phenotype.
GENETIC INSTABILITY,
CHROMOSOMAL CATASTROPHES AND
CONSPIRING CLONES
 A new class of mutational processes is identified
by whole genome sequencing that cause
enormous changes to the genome in a single or
very few cell divisions.
 Chromothripsis - Shattering of chromosomes
into many parts and their (partial) reassembly into
a different order.
 Chromoplexy – interleaved chromosomal
alterations that involve multiple chromosomes.
GENETIC INSTABILITY,
CHROMOSOMAL CATASTROPHES AND
CONSPIRING CLONES
Chromothripsis can be seen in at least 2-3 % of all cancers
across many subtypes and is present in 25% of bone
cancers.
GENETIC INSTABILITY,
CHROMOSOMAL CATASTROPHES AND
CONSPIRING CLONES
 Kataegis is a process of clustering of somatic point
mutations in localised regions of the genome.
 HYPOTHESIS : A chromosomal catastrophe in the
form of chromothripsis, chromoplexy or kataegis leads
to generation of a hopeful monster and subsequent
initiation of a Big Bang.
 Drivers of clonal expansion in tumours can be a
growth factor produced by one clone and used by
another. Hence, phenotypic changes need not be
elicited by genotypic changes in the expanding clone
CONCLUSION
 Colorectal adenomas considered to be precursor
to colorectal cancer may be sitting static for 10-
15 years and progress through punctuated
genetic events to eventually develop the invasive
phenotype or may not progress.
 Once invasion occurs there is a ‘flat’ clonal
expansion and progression to advanced
carcinoma can be quite rapid.
 The fact that genetic progression occurs in
spatially segregated clones is immaterial-
CONCLUSION
 Question arises: in patients with resected
adenomas by looking at the genotype/phenotype
of the index adenoma(s) can we predict future
cancer risk ??
 Whether or not imminent Big Bang can be
detected before the ‘explosion’ happens??
 The answer is further research.
CONCLUSION
 In Barrett’s oesophagus, most Barrett’s segments
are non-progressors.
 Genetic progression in Barrett’s oesophagus
does not progress in selective sweeps . The
individual clones expand independently and can
be a focal event.
 Barrett’s segments can be long-over 10cm and
even the most invasive screening/ surveillance
protocols cannot be expected to pick up such
localised events.
Finding the right model for cancer
progression could be rate limiting
for the design of appropriate
methods of preventing and
treating cancer
TAKE HOME MESSAGE
 Most pre-malignant and preinvasive lesions
(DCIS, colorectal adenomas, Barrett’s
oesophagus) will not progress to malignancy.
 The main driver mutations occur early in the
neoplastic process in many tumour types
suggesting tumour is ‘borne to be bad’.
 Tumour progression can be very fast, may be the
basis of ‘interval cancers’- missed on surveillance
in Barrett’s oesophagus.
 Future research is needed to identify rapidly
progressive pre-malignant and pre-invasive
lesions in order to tailor therapy appropriately
THANK
YOU

More Related Content

What's hot

Microsatellite instability - What is it? How to test? Applications in Medical...
Microsatellite instability - What is it? How to test? Applications in Medical...Microsatellite instability - What is it? How to test? Applications in Medical...
Microsatellite instability - What is it? How to test? Applications in Medical...Venkata pradeep babu koyyala
 
Role of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursRole of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursariva zhagan
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaDr. Liza Bulsara
 
Molecular diagnostics of colorectal cancer
Molecular diagnostics   of colorectal cancerMolecular diagnostics   of colorectal cancer
Molecular diagnostics of colorectal cancerAddisu Alemu
 
IHC in breast pathology
IHC in breast pathologyIHC in breast pathology
IHC in breast pathologynamrathrs87
 
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIASROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIASHajra Mehdi
 
Pitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodPitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodSonic V S
 
Small round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADASmall round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADANarmada Tiwari
 
CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??! CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??! Ashish Jawarkar
 
Microsatellite instability
Microsatellite instability  Microsatellite instability
Microsatellite instability dhanya89
 
The Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary CytologyThe Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary CytologyRawa Muhsin
 
Recent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular NodulesRecent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular NodulesDr Niharika Singh
 
Liquid biopsy
Liquid biopsyLiquid biopsy
Liquid biopsyDr kusuma
 

What's hot (20)

Yokohama system cytology
Yokohama system cytologyYokohama system cytology
Yokohama system cytology
 
Microsatellite instability - What is it? How to test? Applications in Medical...
Microsatellite instability - What is it? How to test? Applications in Medical...Microsatellite instability - What is it? How to test? Applications in Medical...
Microsatellite instability - What is it? How to test? Applications in Medical...
 
Role of ihc on soft tissue tumours
Role of ihc on soft tissue tumoursRole of ihc on soft tissue tumours
Role of ihc on soft tissue tumours
 
Minimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemiaMinimal Residual Disease in Acute lymphoblastic leukemia
Minimal Residual Disease in Acute lymphoblastic leukemia
 
Molecular diagnostics of colorectal cancer
Molecular diagnostics   of colorectal cancerMolecular diagnostics   of colorectal cancer
Molecular diagnostics of colorectal cancer
 
Bal fluid analysis
Bal fluid analysisBal fluid analysis
Bal fluid analysis
 
Imprint cytology
Imprint cytology Imprint cytology
Imprint cytology
 
IHC in breast pathology
IHC in breast pathologyIHC in breast pathology
IHC in breast pathology
 
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIASROLE OF FLOW CYTOMETRY IN LEUKEMIAS
ROLE OF FLOW CYTOMETRY IN LEUKEMIAS
 
Pitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhoodPitfalls in diagnosis of soft tissue tumors of childhood
Pitfalls in diagnosis of soft tissue tumors of childhood
 
Small round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADASmall round cell_tumor_DR NARMADA
Small round cell_tumor_DR NARMADA
 
CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??! CYTOLOGY OF BREAST LESIONS??!
CYTOLOGY OF BREAST LESIONS??!
 
Microsatellite instability
Microsatellite instability  Microsatellite instability
Microsatellite instability
 
Acute Leukemia Cytogenetics
Acute Leukemia CytogeneticsAcute Leukemia Cytogenetics
Acute Leukemia Cytogenetics
 
Renal pediatric tumors
Renal pediatric tumorsRenal pediatric tumors
Renal pediatric tumors
 
The Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary CytologyThe Paris System for Reporting Urinary Cytology
The Paris System for Reporting Urinary Cytology
 
Recent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular NodulesRecent Advances:Hepatocellular Nodules
Recent Advances:Hepatocellular Nodules
 
Liquid biopsy
Liquid biopsyLiquid biopsy
Liquid biopsy
 
Liquid Biopsy
Liquid BiopsyLiquid Biopsy
Liquid Biopsy
 
Premalignant lesions
Premalignant lesionsPremalignant lesions
Premalignant lesions
 

Similar to Genetic origins of human cancer - recent advances

بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.pptosama727046
 
Colorectal molecular pathophysiology.ppt
Colorectal molecular pathophysiology.pptColorectal molecular pathophysiology.ppt
Colorectal molecular pathophysiology.pptkatanchhabra
 
Cancer invasion and metastasis
Cancer invasion and metastasisCancer invasion and metastasis
Cancer invasion and metastasisNilesh Kucha
 
RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.
RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.
RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.varshawadnere
 
Leukemic stem cells
Leukemic stem cellsLeukemic stem cells
Leukemic stem cellsmds-web
 
Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...breastcancerupdatecongress
 
oncogenesis us the study of cancerous cells
oncogenesis us the study of cancerous cellsoncogenesis us the study of cancerous cells
oncogenesis us the study of cancerous cellsmaryamsarwar17
 
Stem Cells in Cancer: A Review
Stem Cells in Cancer:  A ReviewStem Cells in Cancer:  A Review
Stem Cells in Cancer: A ReviewJovana Grbic
 
Tumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asTumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asmds-web
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptxSAMOEINESH
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptxSAMOEINESH
 
Como afrontar células madre de cáncer con alimentos
Como afrontar células madre de cáncer con  alimentos Como afrontar células madre de cáncer con  alimentos
Como afrontar células madre de cáncer con alimentos Nutriline SRL
 

Similar to Genetic origins of human cancer - recent advances (20)

بدر الشهاري.ppt
بدر الشهاري.pptبدر الشهاري.ppt
بدر الشهاري.ppt
 
Colorectal molecular pathophysiology.ppt
Colorectal molecular pathophysiology.pptColorectal molecular pathophysiology.ppt
Colorectal molecular pathophysiology.ppt
 
Cancer invasion and metastasis
Cancer invasion and metastasisCancer invasion and metastasis
Cancer invasion and metastasis
 
RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.
RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.
RECENT DEVELOPMENT IN CANCER PHYTOTHERAPY.
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
13-chap-24-lecture.ppt
13-chap-24-lecture.ppt13-chap-24-lecture.ppt
13-chap-24-lecture.ppt
 
Anticancer.ppt
Anticancer.pptAnticancer.ppt
Anticancer.ppt
 
Leukemic stem cells
Leukemic stem cellsLeukemic stem cells
Leukemic stem cells
 
Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...Alain Toledano : Test and genomic profile : what future in breast cancer trea...
Alain Toledano : Test and genomic profile : what future in breast cancer trea...
 
oncogenesis us the study of cancerous cells
oncogenesis us the study of cancerous cellsoncogenesis us the study of cancerous cells
oncogenesis us the study of cancerous cells
 
Field cancerization
Field cancerizationField cancerization
Field cancerization
 
Stem Cells in Cancer: A Review
Stem Cells in Cancer:  A ReviewStem Cells in Cancer:  A Review
Stem Cells in Cancer: A Review
 
Tumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer asTumor stem cell reprogramming as a driver of cancer as
Tumor stem cell reprogramming as a driver of cancer as
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
 
5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx5. CARCINOMA OF PROSTRATE.pptx
5. CARCINOMA OF PROSTRATE.pptx
 
poster
posterposter
poster
 
ch7neoplasia-.pptx
ch7neoplasia-.pptxch7neoplasia-.pptx
ch7neoplasia-.pptx
 
Como afrontar células madre de cáncer con alimentos
Como afrontar células madre de cáncer con  alimentos Como afrontar células madre de cáncer con  alimentos
Como afrontar células madre de cáncer con alimentos
 

Recently uploaded

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexClive Bates
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Catherine Liao
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...Catherine Liao
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawahpal078100
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...KavyasriPuttamreddy
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxBright Chipili
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramLevi Shapiro
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...kevinkariuki227
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Catherine Liao
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxDr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsSavita Shen $i11
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...Catherine Liao
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Catherine Liao
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentabdeli bhadarva
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfDr Jeenal Mistry
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxdrwaque
 

Recently uploaded (20)

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 

Genetic origins of human cancer - recent advances

  • 1. Dr. Anshulekha Patel Moderator- Dr. (Prof) P.K.Satpathy Guide-Dr. (Prof) Raghumani Mohanty GENETIC ORIGINS OF HUMAN CANCER- RECENT ADVANCES
  • 2. INTRODUCTION  1916 : Tyzzer first use the term ‘somatic mutation’ to designate events occuring in cancer progression.  1954 : Armitage and Doll proposed multi-stage theory of carcinogenesis  1971 : Knudson proposed two-hit model of retinoblastoma  1990: Fearson and Vogelstein analysed colorectal tumour progression and provided support for multistep cancer progression model.
  • 5. THE MULTISTEP CANCER PROGRESSION MODEL  Tumors progressively accumulate carcinogenic mutations or other genetic changes.  The alterations involve tumour suppressor genes and oncogenes and occur in a stepwise fashion.  Multistep cancer progression model emphasises on the order in which the genetic changes occur.  It provides the basis for initiation, growth , progression and metastatic spread of cancer.
  • 7. THE MULTISTEP CANCER PROGRESSION MODEL  Colorectal cancer  Pancreatic cancer  Breast cancer  During progressive clonal evolution, selectively advantageous ‘driver’ lesions lead to acquisition of the phenotypic ‘hallmarks of cancer’.
  • 9. THE MULTISTEP CANCER PROGRESSION MODEL  An initial mutation that confers a selective advantage is acquired by a cell and leads to clonal expansion of these cells.  The first cell is probably a stem cell.  A further mutation occurs which is again selected to clonally expand replacing the other cells in the population- this is called selective sweep.
  • 10. SEQUENTIAL MODEL OF CANCER PROGRESSION Subsequent mutations in the key driver genes to cells within the clone trigger subsequent clonal expansions, and each clone takes over the entire neoplasm (A SWEEP TO FIXATION)
  • 11. THE MULTISTEP CANCER PROGRESSION MODEL  The accural of driver mutations in this stepwise fashion underpins the progression to an invasive or metastatic phenotype.  In the colon, genetic model involves sequential mutations in the APC, KRAS and TP53 genes.  In Barrrett’s oesophagus, early mutation of p16 is followed by later inactivation of TP53.
  • 13. BARRETT’S OESOPHAGUS  The pattern of mutation and clonal expansion as proposed by Maley et al.  An initial founder mutation, usually LOH of p16, provides a cell with a selective advantage and so it sweeps across the entire Barrett's oesophagus segment to fixation. Subsequent mutations and selective sweeps, typically a second hit at the p16 locus or a mutation or LOH of p53 cause later selective sweeps, sometimes also to fixation. The linear accumulation of mutations eventually produces a cancerous clone.
  • 18. COLORECTAL TUMORIGENESIS  Based on assumption that all somatic mutations occurred clonally in an adenoma- present in all its cells, but beginning with the cell of origin or stem cell.  The mutations accumulate within the adenoma by wave of selective sweeps, which go to fixation throughout the adenoma.  So, it follows that adenomas should be ‘ genetically homogenous benign lesion(s)’.
  • 19. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL
  • 20. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL  It suggests there has to be an order in which mutations occur.  Clinically this is appealing –might be amenable to therapeutic attack and milestones of prognosis  Eg in the progression of Barrett’s oesophagus, p16 deletion is followed by loss of TP53. So, TP53 lesion is closer to becoming cancerous…….?? Such deterministic progression with a fixed order of selection is UNLIKELY
  • 21. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL  Tumours develop through variable pathways, and that the order of mutation/ selection is mainly stochastic.  Microenvironment plays an important role in the selection for mutant genes.  Driver mutations are detected in normal tissue. Eg p53 and oncogene mutations in both skin and nondysplastic colon epithelium in inflammatory bowel disease.
  • 22. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL  Selective sweeps are rare in human tumours.  Studies on Barrett’s oesophagus supported concept of small, localised clonal expansions.
  • 24. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL •Multiple clones exist throughout the follow-up period. •In only one case, a clone grew to dominate the Barrett’s segment without real evidence that the clone swept to fixation.
  • 25. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL  In colorectal adenomas progressing to carcinomas, there are no selective sweeps.  Adenomas are not genetically homogenous but they show a complex regional genetic structure, with segregated clones that correlate with the histological appearances.
  • 26. PROBLEMS WITH THE CLASSICAL MULTISTEP CANCER PROGRESSION MODEL  Genetic mosaicism is a feature of most, if not all, cancers.  Kidney cancer  Lung cancer  Breast  Glioma  Leukemia  Ovary  Genetic differences are observed between primary tumour and associated metastases.
  • 27. Assumption made in the classical multistep cancer progression model- that mutations sequentially spread throughout the tumour, creating a genetically homogenous lesion in which all cells share the same mutations- are inconsistent with currently available data.
  • 28. A BIG BANG  A new proposed model of colorectal cancer growth.
  • 29. A BIG BANG  Colorectal cancers grow as a single(clonal) expansion rather than evolving sequentially via multiple selective sweeps.  Composition of subclones that naturally arise within the single expansion do not experience stringent( differential) selection. That means tumour are heterogenous. Acquiring a new driver mutation doesnot trigger a selective sweep.  Because of lack of selection, the timing of mutation, rather than selection, is main determinant of clone size within the tumour. Mutations arising early will tend to have large subclones and those arising late will form clones of restricted size.
  • 30. A BIG BANG  The Big Bang model was postulated to explain the results of a detailed genetic analysis of intratumour diversity in colorectal cancers and adenoma.  The spatial distribution of point mutations and copy number alterations across different regions of these tumours was recorded and computational modelling approach was used to determine the most likely way in which tumour would progress.
  • 31. A BIG BANG  The computational analysis revealed that sequential model was extremely unlikely to explain the obsereved spatial distribution of subclones.  It predicted that all the sizeable subclones arose early during the cancer expansion, and their size was not determined by their fitness.  But it is based on the fact that a tumour consists of an almost innumerable population of cells. 1 cm3 tumour is lower size limit of clinical detection but already contains one billion cells.
  • 33. After initiation, a tumor grows predominantly as a single expansion numerous heterogeneous subclones. ITH results from private alterations (colored arrowheads) that contin accumulate owing to replication errors.
  • 34. ABSTRACT OF BIG BANG ARTICLE  What happens in early, still undetectable human malignancies is unknown because direct observations are impractical. Here we present and validate a 'Big Bang' model, whereby tumors grow predominantly as a single expansion producing numerous intermixed subclones that are not subject to stringent selection and where both public (clonal) and most detectable private (subclonal) alterations arise early during growth. Genomic profiling of 349 individual glands from 15 colorectal tumors showed an absence of selective sweeps, uniformly high intratumoral heterogeneity (ITH) and subclone mixing in distant regions, as postulated by our model. We also verified the prediction that most detectable ITH originates from early private alterations and not from later clonal expansions, thus exposing the profile of the primordial tumor. Moreover, some tumors appear 'born to be bad', with subclone mixing indicative of early malignant potential. This new model provides a quantitative framework to interpret tumor growth dynamics and the origins of ITH, with important clinical implications.
  • 35. AVENUE FOR FUTURE RESEARCH  Clinically, the Big Bang model raises the question of whether cancers are ‘ born to be bad.’  If the clonal composition of the tumour is essentially fixed from the outset of tumour growth, then the early events will determine the prognosis of tumour and its sensitivity to treatment.  In Authors’ opinion Big Bang dynamics could apply equally well in other tumour types but is still undetermined.
  • 36. PUNCTUATED EQUILIBRIA AND HOPEFUL MONSTERS Sequential model assumes that the driver mutations accrue sequentially (phyletic gradualism) Big bang model is an example of punctuated equilibrium. Large phenotypic leaps occur suddenly in a static population
  • 37. PUNCTUATED EQUILIBRIA AND HOPEFUL MONSTERS  Punctuated equilibria evolutionary model is a model purely of the pattern of phenotypic change in a population.  It makes no comment on pattern of genotypic change.  Genotypic phenotype relationship is complex. 1. Small genotype changes can have large phenotypic consequences.(eg. single base pair change in APC cause Hereditary polyosis syndrome) 2. Cell’s phenotype is defined in conjunction with
  • 38. PUNCTUATED EQUILIBRIA AND HOPEFUL MONSTERS  Individuals with grossly altered genomes are referred to as ‘hopeful monsters’.  ‘Hopefulness’ derives from the chance that the alterations will provide significant increase in fitness to the mutated individual.  Question arises: Is the development of a hopeful monster a plausible cause of Big Bang????
  • 39. GENETIC INSTABILITY, CHROMOSOMAL CATASTROPHES AND CONSPIRING CLONES  85% of colon cancers show chromosomal instability (CIN) in the form of loss and gain of whole chromosome arms.  15% show increased point mutations that lead to defect in mismatch repair (MMR) or defect in other DNA replication and repair enzymes.  Both causes elevated rates of ongoing genetic change, and increase the rate at which driver mutations accrue.
  • 40. MICROSATELLITE INSTABILITY (MSI)  MSI is a result of defects in the mismatch repair proteins (genes) hMSH2, hMLH1,hPMS1,hPMS2,and hMSH6.  MSI-H cancers tend to be diploid and have wild type p53 compared with MSS cancers.  MSI-H present at a lower stage and have better survival. INSTABILITY IN TUMOUR CELLS NIH classification 30% (≥ 2 of 5 microsatellites) MSI-H 10-30% MSI-L <10% MSS
  • 41. GENETIC INSTABILITY, CHROMOSOMAL CATASTROPHES AND CONSPIRING CLONES  A steady accural of mutations could underpin punctuated evolution if certain conditions are met 1. Driver mutation must be rare enough that periods of time sufficient for a selective sweep elapse between each sequential driver mutation. 2. The accrual of a single new driver mutation must cause a significant change in phenotype.
  • 42. GENETIC INSTABILITY, CHROMOSOMAL CATASTROPHES AND CONSPIRING CLONES  A new class of mutational processes is identified by whole genome sequencing that cause enormous changes to the genome in a single or very few cell divisions.  Chromothripsis - Shattering of chromosomes into many parts and their (partial) reassembly into a different order.  Chromoplexy – interleaved chromosomal alterations that involve multiple chromosomes.
  • 43. GENETIC INSTABILITY, CHROMOSOMAL CATASTROPHES AND CONSPIRING CLONES Chromothripsis can be seen in at least 2-3 % of all cancers across many subtypes and is present in 25% of bone cancers.
  • 44.
  • 45. GENETIC INSTABILITY, CHROMOSOMAL CATASTROPHES AND CONSPIRING CLONES  Kataegis is a process of clustering of somatic point mutations in localised regions of the genome.  HYPOTHESIS : A chromosomal catastrophe in the form of chromothripsis, chromoplexy or kataegis leads to generation of a hopeful monster and subsequent initiation of a Big Bang.  Drivers of clonal expansion in tumours can be a growth factor produced by one clone and used by another. Hence, phenotypic changes need not be elicited by genotypic changes in the expanding clone
  • 46. CONCLUSION  Colorectal adenomas considered to be precursor to colorectal cancer may be sitting static for 10- 15 years and progress through punctuated genetic events to eventually develop the invasive phenotype or may not progress.  Once invasion occurs there is a ‘flat’ clonal expansion and progression to advanced carcinoma can be quite rapid.  The fact that genetic progression occurs in spatially segregated clones is immaterial-
  • 47. CONCLUSION  Question arises: in patients with resected adenomas by looking at the genotype/phenotype of the index adenoma(s) can we predict future cancer risk ??  Whether or not imminent Big Bang can be detected before the ‘explosion’ happens??  The answer is further research.
  • 48. CONCLUSION  In Barrett’s oesophagus, most Barrett’s segments are non-progressors.  Genetic progression in Barrett’s oesophagus does not progress in selective sweeps . The individual clones expand independently and can be a focal event.  Barrett’s segments can be long-over 10cm and even the most invasive screening/ surveillance protocols cannot be expected to pick up such localised events.
  • 49. Finding the right model for cancer progression could be rate limiting for the design of appropriate methods of preventing and treating cancer
  • 50. TAKE HOME MESSAGE  Most pre-malignant and preinvasive lesions (DCIS, colorectal adenomas, Barrett’s oesophagus) will not progress to malignancy.  The main driver mutations occur early in the neoplastic process in many tumour types suggesting tumour is ‘borne to be bad’.  Tumour progression can be very fast, may be the basis of ‘interval cancers’- missed on surveillance in Barrett’s oesophagus.  Future research is needed to identify rapidly progressive pre-malignant and pre-invasive lesions in order to tailor therapy appropriately

Editor's Notes

  1. Genetic architecture of an early human colorectal cancer. Genotyping of driver genes at a gland by gland level within a human adenoma containing a focus of invasion revealed spatially variegated clones and no clonal sweeps. The lack of clonal sweeps is further illustrated by the inferred phylogenetic tree.